Bicara Therapeutics (BCAX) Q3 2025 Earnings

Aug 12Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.6
-1.18
-0.75
-0.33

Details

Expected EPS
-0.554043
Actual EPS
-0.5
Surprise EPS
0.05
Surprise Percent
+9.75%

Description

⁨Bicara Therapeutics⁩ (⁦BCAX⁩) has reported earnings of ⁦-0.5⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts